Literature DB >> 15327968

Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.

Jye-Yee Lin1, Takayuki Ohshima, Kunitada Shimotohno.   

Abstract

Small ubiquitin-like modifier-1 (SUMO-1) conjugation to the tumor suppressor protein p53 seems to be regulated by murine double minute 2 homologue (Mdm2). It is thought that the physical association of Mdm2 with p53 is important for the enhancement of SUMO-1 conjugation to p53. However, mutant p53 that does not associate with Mdm2 is still sumoylated, albeit at a reduced level, suggesting that sumoylation of p53 is independent of the presence of Mdm2 and there is a direct association of ubiquitin-conjugating enzyme 9 (Ubc9), an E2 ligase for sumoylation, with p53. Here, we report evidence of the direct interaction of Ubc9 with p53. Furthermore, we observed that the interaction of Ubc9 with p53 was regulated by phosphorylation of p53. In particular, in cells treated with adriamycin that is a DNA damaging agent and that enhances phosphorylation of p53 at Ser-20, SUMO conjugation of p53 was severely impaired possibly by reduced affinity of Ubc9 to p53.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327968     DOI: 10.1016/j.febslet.2004.07.059

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

2.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

3.  Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1.

Authors:  Joseph-Anthony T Tan; Jing Song; Yuan Chen; Linda K Durrin
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

4.  MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.

Authors:  Jeong-Yeon Lee; Hee-Young Won; Ji-Hye Park; Hye-Yeon Kim; Hee-Joo Choi; Dong-Hui Shin; Ju-Hee Kang; Jong-Kyu Woo; Seung-Hyun Oh; Taekwon Son; Jin-Woo Choi; Sehwan Kim; Hyung-Yong Kim; Kijong Yi; Ki-Seok Jang; Young-Ha Oh; Gu Kong
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

5.  The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.

Authors:  Richard L Bennett; Yu Pan; Jaime Christian; Teng Hui; W Stratford May
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 6.  p53 N-terminal phosphorylation: a defining layer of complex regulation.

Authors:  Lisa M Miller Jenkins; Stewart R Durell; Sharlyn J Mazur; Ettore Appella
Journal:  Carcinogenesis       Date:  2012-04-12       Impact factor: 4.944

7.  Inhibition of DNA binding by differential sumoylation of heat shock factors.

Authors:  Julius Anckar; Ville Hietakangas; Konstantin Denessiouk; Dennis J Thiele; Mark S Johnson; Lea Sistonen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 8.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

9.  Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications.

Authors:  C Oberle; C Blattner
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

10.  Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression.

Authors:  Pawan Gupta; Ping-Chih Ho; Md Mostaqul Huq; Sung Gil Ha; Sung Wook Park; Amjad Ali Khan; Nien-Pei Tsai; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.